Cytomegalovirus infection and chronic hemodialysis.
Serologic and virologic studies of cytomegalovirus (CMV), a virus infection often disseminated in immunosuppressed patients, were initiated among hemodialysis patients, home dialysis partners, hemodialysis center personnel, and several groups of patients. No evidence was found of activation or persistence of CMV infections in connection with chronic renal disease or in association with hemodialysis. Evidence of increased CMV activation and/or infection was found among individuals who had re-entered the dialysis program following renal allograft rejection. The data indicate that dialysis personnel and home dialysis partners are not at increased risk for CMV infection. The findings of this study, which contrast with those pertaining to hepatitis B infection, suggest that different mechanisms are responsible for establishing both infection and persistence of CMV and hepatitis B.
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D003168:Complement Fixation Tests; D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000276:immunology; D005260:Female; D006331:Heart Diseases / Q000276:immunology / Q000382:microbiology; D006437:Hemodialysis, Home / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000276:immunology / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012306:Risk
D000914:Antibodies, Viral